Home / Our Approach

Rigorous by design

A structured, repeatable methodology that turns a fragmented evidence base into conclusions you can defend.

A single substance may be described in a REACH dossier, an ATSDR profile, an IARC monograph, EPA screening data, and hundreds of peer-reviewed studies, and those sources don't always agree. Other substances have almost no data at all. Searching the literature is straightforward. Searching it completely, weighing it correctly, and filling gaps defensibly is the discipline we bring.

Methodology

Five steps to a defensible answer

Establish substance identity

We confirm CAS and EC numbers, synonyms, trade names, composition, and impurity profile. Accurate identification is the foundation of every sound assessment, and of any valid read-across.

Search comprehensively

Each engagement follows a standardized endpoint checklist applied across every relevant public and licensed source, ensuring consistent and complete coverage.

Fill data gaps with read-across

Where substance-specific data is missing, we identify suitable analogues or chemical categories and apply read-across in line with ECHA's Read-Across Assessment Framework and OECD guidance on grouping of chemicals.

Reconcile and weigh the evidence

Where findings diverge, we document the divergence and explain which evidence carries greater scientific and regulatory weight, and why.

Deliver focused conclusions

You receive an answer to your question, not an unfiltered literature compilation. Every statement is referenced to its source and date of access, and every read-across is identified as such.

Read-across

When data is missing, we don't guess

Many substances in commerce have never been fully tested. Read-across is the scientifically recognized way to address this: data from structurally and mechanistically similar substances is used to predict the properties of the substance in question. Regulators, including ECHA, accept it when it is properly justified.

We document every read-across in full: the analogues selected, the structural and mechanistic basis for similarity, the data carried across, and an explicit statement of uncertainty. You and any reviewer can judge its strength for yourselves.

Source analogue ARobust test data available
Target substanceData gap for endpoint
Source analogue BSupporting data
Documented predictionWith justification and confidence level

Similarity is established on structure, physicochemical properties, metabolism, and mode of action, not structure alone.

An analytical firm, by deliberate choice

ChemVigil doesn't perform laboratory testing. This independence is intentional. With no stake in any study outcome, our sole interest is an accurate and impartial reading of the evidence.

Where published data and read-across together are insufficient to support a conclusion, we state this plainly and identify precisely where new testing would add value. We will never present a limited evidence base as a complete one.

Our quality standards

  • Standardized templates and endpoint checklists
  • Full referencing with access dates
  • Documented justification for every read-across
  • Independent second review of every deliverable
  • Version-controlled reports for complete traceability
  • Clear statement of confidence and data gaps in every report
What you receive

Reports built for the people who have to act on them

Executive summary first

The conclusions, the confidence we place in them, and the actions they imply, on the first page. The supporting detail follows for those who need it.

A complete source register

Every source consulted, whether or not it changed the conclusion, listed with its version and date of access so the analysis can be reproduced.

A briefing, not just a document

Every engagement closes with a walkthrough of the findings, so your team leaves with answers rather than a reading assignment.

See our methodology applied to your substance

Share the chemical and your timeline. We'll scope the work in a single conversation.

Request a Consultation